SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-22-002887
Filing Date
2022-11-02
Accepted
2022-11-02 11:58:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da113506002_11012022.htm SC 13D/A 120675
2 LETTER TO THE BOARD, DATED NOVEMBER 2, 2022 ex991to13da113506002_110122.htm EX-99.1 26549
3 GRAPHIC image_001.jpg GRAPHIC 2078
  Complete submission text file 0000921895-22-002887.txt   151749
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92222 | Film No.: 221352923
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Filed by) CIK: 0001845711 (see all company filings)

IRS No.: 000000000 | State of Incorp.: O1 | Fiscal Year End: 1231
Type: SC 13D/A